inhibition of axl signaling in antimetastatic therapy.

摘要

inhibition of axl signaling in antimetastatic therapy. Compositions and methods are provided for alleviating cancer in a mammal by administering a therapeutic dose of a pharmaceutical composition that inhibits ax1 protein activity, for example by competitive or non-competitive inhibition of the binding interaction between axl and its gas6 ligand.